• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SOM
Click for more information
0.00% 29.0¢

SOMNOMED LIMITED - Announcements

Market Cap $95.08M  ! watchlist Created with Sketch. Add to my watchlist

SomnoMed Limited is an Australia-based company, which is engaged in producing and selling... SomnoMed Limited is an Australia-based company, which is engaged in producing and selling devices for the oral treatment of sleep-related disorders. The Company provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is focused on the commercialization of the SomnoDent and other oral devices for sleep-related disorders. The Company’s segments include North America, Europe, Asia Pacific, CORE, and RSS. Its SomnoDent product line includes SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, SomnoDent Fusion, Herbst Advance Elite and Herbst Advance. Its SomMorning Repositioner is designed to help return their mandible back to its pre-treatment centric position. Its SomnoBrux Michigan splint is a custom fit, acrylic splint (dental guard) for upper teeth designed to protect the teeth from grinding and scraping during Bruxism. It also offers SomTabs, which are cleaning tablets that are developed to clean oral appliances.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
SOM Trading updatePRICE SENSITIVE25/03/19
SOM Change in substantial holding from AEF11/03/19
SOM S&P DJI Announces March 2019 Quarterly RebalancePRICE SENSITIVE08/03/19
SOM Investor PresentationPRICE SENSITIVE21/02/19
SOM Half Yearly Report and AccountsPRICE SENSITIVE21/02/19
SOM Core revenue growth up 13% in Q2PRICE SENSITIVE29/01/19
SOM Appendix 4C - quarterlyPRICE SENSITIVE29/01/19
SOM Results of Meeting27/11/18
SOM 2018 AGM addresses - Chairman and CEOPRICE SENSITIVE27/11/18
SOM Appendix 3B19/11/18
SOM Material terms of employment agreement CEO19/11/18
SOM Change in Leadership of SomnoMedPRICE SENSITIVE19/11/18
SOM Response to Appendix 4C QueryPRICE SENSITIVE05/11/18
SOM Strong first quarter in Core business diluted by RSS resultsPRICE SENSITIVE26/10/18
SOM Appendix 4C - quarterlyPRICE SENSITIVE26/10/18
SOM Proxy Form Annual General Meeting15/10/18
SOM Notice of Annual General Meeting15/10/18
SOM Appendix 3B03/10/18
SOM 2018 Annual Report Typographical error28/09/18
SOM 2018 Annual Report Typograhical error28/09/18
SOM Appendix 4G & Corporate Governance19/09/18
SOM Annual Report to shareholders19/09/18
SOM Investor presentationPRICE SENSITIVE22/08/18
SOM Full year results and the consolidation of RSS operationsPRICE SENSITIVE22/08/18
SOM Preliminary Final ReportPRICE SENSITIVE22/08/18
SOM 2018 Full Year Results Webcast16/08/18
SOM Appendix 4C - quarterlyPRICE SENSITIVE25/07/18 download Created with Sketch. 346.95KB
SOM SomnoMed posts 30% revenue growth for FY2018PRICE SENSITIVE25/07/18 download Created with Sketch. 193.01KB
SOM Change in substantial holding from AEF25/06/18 download Created with Sketch. 145.54KB
SOM Becoming a substantial holder from AEF22/06/18 download Created with Sketch. 232.53KB
SOM Change of Director's Interest Notice14/06/18 download Created with Sketch. 258.87KB
SOM Change in substantial holding14/06/18 download Created with Sketch. 195.91KB
SOM Ceasing to be a substantial holder13/06/18 download Created with Sketch. 127.92KB
SOM Change in substantial holding08/06/18 download Created with Sketch. 197.33KB
SOM Change of Director's Interest Notice08/06/18 download Created with Sketch. 225.56KB
SOM Trading UpdatePRICE SENSITIVE24/05/18 download Created with Sketch. 255.27KB
SOM Initial Director's Interest Notice02/05/18
SOM Appointment of a Director30/04/18
SOM Strong revenue growth continues23/04/18
SOM Appendix 4C - quarterlyPRICE SENSITIVE23/04/18
SOM Becoming a substantial holder16/04/18
SOM Change in substantial holding22/03/18
SOM Change of Director's Interest Notice22/03/18
SOM Change of Director's Interest Notice22/03/18
SOM Shareholder distribution information22/03/18
SOM Appendix 3B22/03/18
SOM Results of Retail Entitlement OfferPRICE SENSITIVE19/03/18
SOM Change of Director's Interest Notice28/02/18
SOM Appendix 3B27/02/18
SOM Dispatch of Retail Entitlement Offer documents26/02/18
SOM Retail Entitlement Offer Information BookletPRICE SENSITIVE21/02/18
SOM Successful completion of Institutional Entitlement OfferPRICE SENSITIVE21/02/18
SOM Appendix 3B19/02/18
SOM Letter to ineligible shareholders19/02/18
SOM Cleansing Notice19/02/18
SOM Half Year AccountsPRICE SENSITIVE19/02/18
SOM Investor Presentation19/02/18
SOM Accelerated non-renounceable entitlement offerPRICE SENSITIVE19/02/18
SOM ASX Market Release - Trading HaltPRICE SENSITIVE19/02/18
SOM Appendix 4C - quarterlyPRICE SENSITIVE24/01/18
SOM Revenue growth up 45% in Q2PRICE SENSITIVE24/01/18
SOM Ceasing to be a substantial holder from AEF12/12/17
SOM Results of Meeting20/11/17
SOM Good revenue growth for the quarterPRICE SENSITIVE26/10/17
SOM Appendix 4C - quarterlyPRICE SENSITIVE26/10/17
SOM Proxy Form16/10/17
SOM Notice of Annual General Meeting16/10/17
SOM Change of Director's Interest Notice05/10/17
SOM Appendix 3B05/10/17
SOM Corporate Governance Statement and Appendix 4G25/09/17
SOM Annual Report to shareholders25/09/17
SOM Appendix 3B12/09/17
SOM Change in substantial holding08/09/17
SOM Investor PresentationPRICE SENSITIVE24/08/17
SOM Preliminary Final ReportPRICE SENSITIVE24/08/17
SOM Appendix 4C - quarterlyPRICE SENSITIVE24/07/17
SOM Strong Q4 growth to finish transitional yearPRICE SENSITIVE24/07/17
SOM Change in substantial holding05/07/17
SOM Change in substantial holding12/05/17
SOM Appendix 3B updated04/05/17
SOM Appendix 3B04/05/17
SOM Appendix 4C - quarterlyPRICE SENSITIVE26/04/17
SOM Renew Sleep Solutions well ahead of planPRICE SENSITIVE26/04/17
SOM Investor Presentation23/02/17
SOM Half Year AccountsPRICE SENSITIVE23/02/17
SOM Renew Sleep Solutions opens first two centres in Q2PRICE SENSITIVE23/01/17
SOM Appendix 4C - quarterlyPRICE SENSITIVE23/01/17
SOM Appendix 3B03/01/17
SOM Change of Director's Interest Notice19/12/16
SOM Appendix 3B19/12/16
SOM Change in substantial holding09/12/16
SOM Change in substantial holding01/12/16
SOM Results of Meeting24/11/16
SOM AGM Chairman's Address24/11/16
SOM Appendix 3B-SOM.AX 31/10/16
SOM Appendix 4C - quarterly-SOM.AX PRICE SENSITIVE18/10/16
SOM Sales growth accelerating-SOM.AX PRICE SENSITIVE18/10/16
SOM Proxy Form-SOM.AX 12/10/16
SOM Notice of Annual General Meeting-SOM.AX 12/10/16
SOM Appendix 3B-SOM.AX 07/10/16
SOM Trading update
25/03/19PRICE SENSITIVE
SOM Change in substantial holding from AEF
11/03/19
SOM S&P DJI Announces March 2019 Quarterly Rebalance
08/03/19PRICE SENSITIVE
SOM Investor Presentation
21/02/19PRICE SENSITIVE
SOM Half Yearly Report and Accounts
21/02/19PRICE SENSITIVE
SOM Core revenue growth up 13% in Q2
29/01/19PRICE SENSITIVE
SOM Appendix 4C - quarterly
29/01/19PRICE SENSITIVE
SOM Results of Meeting
27/11/18
SOM 2018 AGM addresses - Chairman and CEO
27/11/18PRICE SENSITIVE
SOM Appendix 3B
19/11/18
SOM Material terms of employment agreement CEO
19/11/18
SOM Change in Leadership of SomnoMed
19/11/18PRICE SENSITIVE
SOM Response to Appendix 4C Query
05/11/18PRICE SENSITIVE
SOM Strong first quarter in Core business diluted by RSS results
26/10/18PRICE SENSITIVE
SOM Appendix 4C - quarterly
26/10/18PRICE SENSITIVE
SOM Proxy Form Annual General Meeting
15/10/18
SOM Notice of Annual General Meeting
15/10/18
SOM Appendix 3B
03/10/18
SOM 2018 Annual Report Typographical error
28/09/18
SOM 2018 Annual Report Typograhical error
28/09/18
SOM Appendix 4G & Corporate Governance
19/09/18
SOM Annual Report to shareholders
19/09/18
SOM Investor presentation
22/08/18PRICE SENSITIVE
SOM Full year results and the consolidation of RSS operations
22/08/18PRICE SENSITIVE
SOM Preliminary Final Report
22/08/18PRICE SENSITIVE
SOM 2018 Full Year Results Webcast
16/08/18
SOM Appendix 4C - quarterly
25/07/18PRICE SENSITIVE download Created with Sketch. 346.95KB
SOM SomnoMed posts 30% revenue growth for FY2018
25/07/18PRICE SENSITIVE download Created with Sketch. 193.01KB
SOM Change in substantial holding from AEF
25/06/18 download Created with Sketch. 145.54KB
SOM Becoming a substantial holder from AEF
22/06/18 download Created with Sketch. 232.53KB
SOM Change of Director's Interest Notice
14/06/18 download Created with Sketch. 258.87KB
SOM Change in substantial holding
14/06/18 download Created with Sketch. 195.91KB
SOM Ceasing to be a substantial holder
13/06/18 download Created with Sketch. 127.92KB
SOM Change in substantial holding
08/06/18 download Created with Sketch. 197.33KB
SOM Change of Director's Interest Notice
08/06/18 download Created with Sketch. 225.56KB
SOM Trading Update
24/05/18PRICE SENSITIVE download Created with Sketch. 255.27KB
SOM Initial Director's Interest Notice
02/05/18
SOM Appointment of a Director
30/04/18
SOM Strong revenue growth continues
23/04/18
SOM Appendix 4C - quarterly
23/04/18PRICE SENSITIVE
SOM Becoming a substantial holder
16/04/18
SOM Change in substantial holding
22/03/18
SOM Change of Director's Interest Notice
22/03/18
SOM Change of Director's Interest Notice
22/03/18
SOM Shareholder distribution information
22/03/18
SOM Appendix 3B
22/03/18
SOM Results of Retail Entitlement Offer
19/03/18PRICE SENSITIVE
SOM Change of Director's Interest Notice
28/02/18
SOM Appendix 3B
27/02/18
SOM Dispatch of Retail Entitlement Offer documents
26/02/18
SOM Retail Entitlement Offer Information Booklet
21/02/18PRICE SENSITIVE
SOM Successful completion of Institutional Entitlement Offer
21/02/18PRICE SENSITIVE
SOM Appendix 3B
19/02/18
SOM Letter to ineligible shareholders
19/02/18
SOM Cleansing Notice
19/02/18
SOM Half Year Accounts
19/02/18PRICE SENSITIVE
SOM Investor Presentation
19/02/18
SOM Accelerated non-renounceable entitlement offer
19/02/18PRICE SENSITIVE
SOM ASX Market Release - Trading Halt
19/02/18PRICE SENSITIVE
SOM Appendix 4C - quarterly
24/01/18PRICE SENSITIVE
SOM Revenue growth up 45% in Q2
24/01/18PRICE SENSITIVE
SOM Ceasing to be a substantial holder from AEF
12/12/17
SOM Results of Meeting
20/11/17
SOM Good revenue growth for the quarter
26/10/17PRICE SENSITIVE
SOM Appendix 4C - quarterly
26/10/17PRICE SENSITIVE
SOM Proxy Form
16/10/17
SOM Notice of Annual General Meeting
16/10/17
SOM Change of Director's Interest Notice
05/10/17
SOM Appendix 3B
05/10/17
SOM Corporate Governance Statement and Appendix 4G
25/09/17
SOM Annual Report to shareholders
25/09/17
SOM Appendix 3B
12/09/17
SOM Change in substantial holding
08/09/17
SOM Investor Presentation
24/08/17PRICE SENSITIVE
SOM Preliminary Final Report
24/08/17PRICE SENSITIVE
SOM Appendix 4C - quarterly
24/07/17PRICE SENSITIVE
SOM Strong Q4 growth to finish transitional year
24/07/17PRICE SENSITIVE
SOM Change in substantial holding
05/07/17
SOM Change in substantial holding
12/05/17
SOM Appendix 3B updated
04/05/17
SOM Appendix 3B
04/05/17
SOM Appendix 4C - quarterly
26/04/17PRICE SENSITIVE
SOM Renew Sleep Solutions well ahead of plan
26/04/17PRICE SENSITIVE
SOM Investor Presentation
23/02/17
SOM Half Year Accounts
23/02/17PRICE SENSITIVE
SOM Renew Sleep Solutions opens first two centres in Q2
23/01/17PRICE SENSITIVE
SOM Appendix 4C - quarterly
23/01/17PRICE SENSITIVE
SOM Appendix 3B
03/01/17
SOM Change of Director's Interest Notice
19/12/16
SOM Appendix 3B
19/12/16
SOM Change in substantial holding
09/12/16
SOM Change in substantial holding
01/12/16
SOM Results of Meeting
24/11/16
SOM AGM Chairman's Address
24/11/16
SOM Appendix 3B-SOM.AX
31/10/16
SOM Appendix 4C - quarterly-SOM.AX
18/10/16PRICE SENSITIVE
SOM Sales growth accelerating-SOM.AX
18/10/16PRICE SENSITIVE
SOM Proxy Form-SOM.AX
12/10/16
SOM Notice of Annual General Meeting-SOM.AX
12/10/16
SOM Appendix 3B-SOM.AX
07/10/16
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
29.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $95.08M
Open High Low Value Volume
29.0¢ 29.5¢ 29.0¢ $7.157K 24.43K

Buyers (Bids)

No. Vol. Price($)
1 10000 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 3200 1
View Market Depth
Last trade - 10.37am 15/11/2024 (20 minute delay) ?
Last
29.0¢ 		  Change
0.000 ( 1.75 %)
Open High Low Volume
28.5¢ 29.0¢ 28.5¢ 6638
Last updated 10.19am 15/11/2024 ?
SOM (ASX) Chart

Top Stories

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.